# PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

> **NIH NIH N02** · UNIVERSITY OF WISCONSIN-MADISON · 2021 · $107,353

## Abstract

The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.

## Key facts

- **NIH application ID:** 10458433
- **Project number:** 261201200033I-P00006-26100011-1
- **Recipient organization:** UNIVERSITY OF WISCONSIN-MADISON
- **Principal Investigator:** HOWARD BAILEY
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $107,353
- **Award type:** —
- **Project period:** 2017-09-15 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10458433

## Citation

> US National Institutes of Health, RePORTER application 10458433, PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER (261201200033I-P00006-26100011-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10458433. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*